Drug Information
Drug General Information | Top | |||
---|---|---|---|---|
Drug ID |
D09LKM
|
|||
Former ID |
DIB021153
|
|||
Drug Name |
Pyrazolo[1,5-a]pyrimidine 3G
|
|||
Synonyms |
KDR/Flk-1 kinase inhibitor IV; pyrazolo[1,5-a]pyrimidine 3g
Click to Show/Hide
|
|||
Drug Type |
Small molecular drug
|
|||
Indication | Discovery agent [ICD-11: N.A.] | Investigative | [1] | |
Structure |
Download2D MOL
|
|||
Formula |
C17H13N3OS
|
|||
Canonical SMILES |
COC1=CC=C(C=C1)C2=CN3C(=C(C=N3)C4=CSC=C4)N=C2
|
|||
InChI |
1S/C17H13N3OS/c1-21-15-4-2-12(3-5-15)14-8-18-17-16(9-19-20(17)10-14)13-6-7-22-11-13/h2-11H,1H3
|
|||
InChIKey |
HBWLNACPIFKNIP-UHFFFAOYSA-N
|
|||
CAS Number |
CAS 216661-57-3
|
|||
PubChem Compound ID | ||||
PubChem Substance ID | ||||
ChEBI ID |
CHEBI:93078
|
References | Top | |||
---|---|---|---|---|
REF 1 | Optimization of a pyrazolo[1,5-a]pyrimidine class of KDR kinase inhibitors: improvements in physical properties enhance cellular activity and pharm... Bioorg Med Chem Lett. 2002 Dec 16;12(24):3537-41. |
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.